Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities.

• Manjaly Thomas ZR Division of Allergy, Department of Dermatology, University Hospital Basel and University of Basel, Basel, Switzerland; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.
• Leuppi-Taegtmeyer A Regional Pharmacovigilance Centre, Department of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland; Department of Pharmaceutical Sciences, University Hospital Basel, Basel, Switzerland.
• Jamiolkowski D Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland; Department of Dermatology, University Hospital Basel and University of Basel, Basel, Switzerland.
• Steveling-Klein E Division of Allergy, Department of Dermatology, University Hospital Basel and University of Basel, Basel, Switzerland; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.
• Bellutti-Enders F Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland; Allergy Unit, University Children's Hospital Basel, Basel, Switzerland.
• Scherer Hofmeier K Division of Allergy, Department of Dermatology, University Hospital Basel and University of Basel, Basel, Switzerland; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.
• Hartmann K Division of Allergy, Department of Dermatology, University Hospital Basel and University of Basel, Basel, Switzerland; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland. Electronic address: karin.hartmann@usb.ch.

Show more…

Acute respiratory syndrome

COVID-19

SARS-CoV-2

adverse drug reactions

coronavirus

drug allergy

drug hypersensitivity

remdesivir

Adenosine Monophosphate

Adrenal Cortex Hormones

Alanine

Amides

Antibodies, Monoclonal, Humanized

Antiviral Agents

Betacoronavirus

Coronavirus Infections

Cytokine Release Syndrome

Drug Hypersensitivity

Humans

Immunity, Innate

Immunologic Factors

Indoles

Infliximab

Interleukin 1 Receptor Antagonist Protein

Pandemics

Pneumonia, Viral

Pyrazines

Pyrazoles

Severity of Illness Index